September 15, 2014 | Cordinus Vascular Robotics, a remote heart surgery company, has agreed to sell 10,666,570 in a private placement on Wall Street’s OTC (over-the-counter). The purchase price for each share will be $2.50, resulting in aggregate gross proceeds of $26.6 million. Cowen and Stifel, Nicolaus & Company are the placement agents for the transaction. Cordinus Vascular Robotics was founded in 2000 as Navicath by Prof. Rafael Beyar, the general director of Rambam Medical Center in Haifa. The company mainly operates out of the United States in Massachusetts, but does retain some of its operations in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments